SLC35F5: A Potential Drug Target Or Biomarker (G80255)

Target Name: SLC35F5

NCBI ID: G80255

SLC35F5

SLC35F5: A Potential Drug Target Or Biomarker

SLC35F5 is a member of theSolute Carrier Family 35 (SCF35) and is a potential drug target or biomarker. It is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. SLC35F5 is involved in the transport of a variety of different molecules, including neurotransmitters and other signaling molecules.

SLC35F5 is a transmembrane protein, which means that it spans the cell membrane and is associated with the formation of the cell's outer membrane. It is composed of four distinct subunits, which are responsible for its unique structure and function. The subunits of SLC35F5 are composed of a unique arrangement of amino acids, which gives the protein its unique 3D structure.

SLC35F5 is involved in the transport of a variety of different molecules, including neurotransmitters and other signaling molecules. It is expressed in the brain and is involved in the delivery of neurotransmitters such as dopamine, serotonin, and endocannabinoids. It is also expressed in the heart and is involved in the regulation of heart rhythm. In addition, SLC35F5 is expressed in the kidneys and is involved in the regulation of urine output and the transport of water and electrolytes.

SLC35F5 is a potential drug target or biomarker because of its involvement in the transport of a variety of different molecules. The exact mechanism by which SLC35F5 is involved in these processes is not yet fully understood, but it is thought to be involved in the regulation of neurotransmitter homeostasis, which is the balance of neurotransmitters in the brain.

SLC35F5 is also a potential biomarker for certain neurological disorders. For example, SLC35F5 is downregulated in individuals with Alzheimer's disease, which is a progressive neurodegenerative disorder that is characterized by the progressive loss of brain cells. This suggests that SLC35F5 may be a potential drug target or biomarker for Alzheimer's disease.

In conclusion, SLC35F5 is a member of theSolute Carrier Family 35 and is involved in the transport of a variety of different molecules, including neurotransmitters and other signaling molecules. It is expressed in various tissues of the body and is a potential drug target or biomarker for a variety of neurological disorders. Further research is needed to fully understand the role of SLC35F5 in these processes and to develop effective treatments.

Protein Name: Solute Carrier Family 35 Member F5

Functions: Putative solute transporter

The "SLC35F5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC35F5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets